The Food and Drug Administration (FDA) is responsible for: A. Requiring drug manufacturers to provide notice that a new drug is safe. B. Recalling pharmaceuticals only after harm has occurred. C. The approval before a new drug can be marketed. D. The assumption that the manufacturer of drugs would have conducted safety tests before marketing a new drug and protocols have been established.

The Food and Drug Administration (FDA) is responsible for: A. Requiring drug manufacturers to provide notice that a new drug is safe. B. Recalling pharmaceuticals only after harm has occurred. C. The approval before a new drug can be marketed. D. The assumption that the manufacturer of drugs would have conducted safety tests before marketing a new drug and protocols have been established.

Essentials of Pharmacology for Health Professions

7th Edition

ISBN:9781305441620

Author:WOODROW

Publisher:WOODROW

ChapterCRE1: Comprehensive Review Exam For Part 1

Section: Chapter Questions

Problem 1CEP1

See similar textbooks

Similar questions

Describe the FDA approval process for assessing the safety and efficacy of a newly developed drug. What are advantages and disadvantages of this process?
Which of the statements below is true about pharmaceutical or drug packaging? a.) FDA maintains tight control over regulations b.) cost is a major consideration when designing a package c.) advertising and communicating with the consumer is important for both prescription and OTC drugs. d.) shelf life is always shorter than for food so must choose material appropriately.
Briefly describe the steps involved in the development and approval of a new drug in the United States: List two pros and two cons about this process and what are your personal thoughts about it
Describe the issues associated with drug safety after FDA approval
Name at least five requirements for a drug to exert its biologic action
Injection safety, or safe injection practices, is a set of measures taken to perform injections in an optimally safe manner for patients, healthcare personnel, and others. Question options: A) True B) False
The acronym, USP, referenced on the Data Analysis page refers to the United States Pharmacopeia. Which of the following statements is not true about the USP? a) mission is to improve global health by issuing public standards and related programs to ensure the quality, safety, and benefits of medicines and foods b) generates chemical reference standards and official test methods for medicines and foods to ensure their quality and safety c) is responsible to provide the U.S. with a reliable, affordable, universal mail service d) is a non-profit scientific organization founded in 1820 in Washington D.C.
Outline the general steps from initial drug discovery to IND filing. Add as much detail as you need and feel free to use flow charts, graphics, visuals, as long as is made by you alone and not directly copied-pasted from another source. If an IND is cleared to proceed by the US-FDA, what is the single most important goal of a first-in-human (FIH) clinical trial?
What is Drugbank? https://go.drugbank.com/ A.A compendium of drugs that are commercially available. B.Drug Gene Interaction database C.FBI storage locker for illegal drugs D. A database of pharmaceutical knowledge about drugs.
Compare and differentiate Investigational New Drug (IND) Application from a New Drug Application (NDA) (In your own words)
Show the relationship of Drug therapy processes to the different branches of Pharmacology.
Which statement is accurate regarding the Dietary Supplement Health and Education Act (DSHEA) of 1994? Select one: a. It mandates that herel product labels contain accurate information. b. It mandates that herbal product labels state that the products are not intended to diagnose, treat, cure, or prevent disease. c. It requires that herbal products undergo the same rigorous testing as drugs do under the FDA.